| Date | Title | Description |
| 12.11.2025 | Laboratory Economics Issues Research Report on U.S. Anatomic Pathology Market | Laboratory Economics has just published the most comprehensive and detailed market research report available on the U.S. Anatomic Pathology Market. This is an ideal resource for preparing business plans and market strategies.
POUGHKEEPSIE, ... |
| 19.09.2025 | T.Rx Capital: $77.5 Million Fund I Launched To Invest In Startups | T.Rx Capital, a newly formed venture capital firm dedicated to early-stage healthcare innovation, has announced the close of its first fund, T.Rx Capital Fund I, at $77.5 million. The fund is focused on supporting visionary founders who are... |
| 19.06.2025 | Американская медицинская компания Caris Life оценена в $7,7 млрд в ходе IPO на Nasdaq | «Мы ждали достижения некоторых ключевых рубежей. Мы погасим часть наших долгов за счет полученных средств и укрепим наш баланс, чтобы иметь возможность инвестировать туда, где это необходимо», — сказал в интервью президент компании Caris Li... |
| 18.06.2025 | Caris Life Sciences Announces Pricing of Initial Public Offering | What You Should Know:
– Caris Life Sciences® (Caris), an AI TechBio company and pioneer in precision medicine, today announced the pricing of its initial public offering (IPO) of 23,529,412 shares of its common stock at a public offering pr... |
| 12.06.2025 | US IPO market revival takes root as Chime soars in debut | US IPO market revival takes root as Chime soars in debut
By Manya Saini and Niket NishantJune 12, 20255:43 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Item 1 of 2 Chime CEO and Co-Founder Ch... |
| 10.06.2025 | Caris Life Sciences Targets $5.3 Billion Valuation in IPO
Only paid subscribers can comment on this post | Caris Life Sciences is a cancer diagnostics company that develops advanced molecular profiling and AI-based technologies to drive precision oncology. Its flagship offering, Caris Molecular Intelligence, analyzes DNA, RNA, and protein data t... |
| 10.04.2025 | Caris Life Sciences: $168 Million Raised For Precision Medicine Platform | Caris Life Sciences – a next-generation AI TechBio company and precision medicine pioneer – announced that the company has closed a growth capital funding round of $168 million. With this round of funding, Caris has raised $1.86 billion in ... |
| 09.04.2025 | Caris Life Sciences collects $168M to fund tumor test rollouts | Caris Life Sciences has collected $168 million in new funding to support the growth of its precision medicine platforms, following the FDA’s approval of its multi-cancer companion diagnostic test last fall.
The financing was led by returnin... |
| 08.04.2025 | Caris Life Sciences: A Giant Leap in Precision Medicine | In the world of biotechnology, innovation is the lifeblood. Caris Life Sciences, a Texas-based company, just took a giant leap forward. It secured $168 million in growth funding, a significant boost for its precision medicine platform. This... |
| 07.04.2025 | Caris Life Sciences Raises $168M in Private Capital | Caris Life Sciences, an Irving, TX-based AI TechBio company and precision medicine provider, raised $168M in Growth funding.
The round was led by Braidwell LP, with participation from new investors Perceptive Advisors, Woodline and Ghisallo... |
| 07.04.2025 | Caris Life Sciences secures $168M for precision medicine platform | Photo: poba/Getty Images
Biotechnology and precision medicine company Caris Life Sciences announced it raised $168 million in growth capital funding.
Caris Life Sciences has now raised $1.86 billion in capital since 2018.
Braidwell LP led t... |
| 16.01.2025 | Oncology: Caris and Ontada Combine Data to Drive Precision Medicine | What You Should Know:
– Caris Life Sciences® (Caris), a pioneer in precision medicine and next-generation AI TechBio innovation, announced a transformative collaboration with Ontada®, a leading organization in oncology real-world evidence, ... |
| 25.06.2024 | Juniper Biologics Revolutionizes Cancer Care in MEA Through Partnership with Caris Life Sciences | In a groundbreaking move, Juniper Biologics, a prominent player in the healthcare and pharmaceutical industry, has expanded its distribution rights for Caris Life Sciences' solid tumour molecular profiling services in the Middle East and Af... |
| 24.06.2024 | Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Molecular Profiling in the Middle East and Africa | SINGAPORE, June 24, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Cari... |
| 23.06.2024 | Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Molecular Profiling in the Middle East and Africa | SINGAPORE, June 23, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Cari... |
| 30.04.2024 | Caris Life Sciences and COTA, Inc. Announce Collaboration to Expand Collective Multi-Modal Data Offering | The combined power of Caris' DNA, RNA, and imaging data with COTA's curated clinical data strengthens the offering to drive next-gen therapeutic development and advance patient care
IRVING, Texas and NEW YORK, April 30, 2024 /PRNewswire/ --... |
| 01.06.2023 | Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform | Caris Life Science(Caris), the leading molecular science, artificial intelligence (AI) and machine learning technology company actively developing and delivering innovative solutions to revolutionize healthcare, and ConcertAI, the leading o... |
| 20.01.2023 | Caris Life Sciences Raises $400 Million in Senior Secured Debt | - |
| 19.01.2023 | Caris Life Sciences Raises $400M to Advance AI-Driven Molecular Profiling to Revolutionize Cancer Care | What You Should Know: |
| 12.01.2023 | JUNIPER BIOLOGICS PARTNERS WITH CARIS LIFE SCIENCES® FOR MOLECULAR PROFILING DISTRIBUTION IN SOUTH EAST ASIA | SINGAPORE, Jan. 11, 2023 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd, a science-led healthcare company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences® (Caris)' ... |
| 12.01.2023 | JUNIPER BIOLOGICS PARTNERS WITH CARIS LIFE SCIENCES® FOR MOLECULAR PROFILING DISTRIBUTION IN SOUTH EAST ASIA | SINGAPORE, Jan. 12, 2023 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd, a science-led healthcare company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences® (Caris)' ... |
| 09.01.2023 | Caris Life Sciences and ConcertAI Form Broad Partnership Creating Industry-Leading Molecular Oncology Research Platform to Accelerate Drug Development and Novel Research | Caris Life Sciences(Caris), the leading molecular science, artificial intelligence (AI) and machine learning technology company actively developing and delivering innovative solutions to revolutionize healthcare, and ConcertAI, the leading ... |
| 21.01.2022 | 5 most popular innovation stories in Houston this week | Editor's note: Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap included news out of the Houston Spaceport, innovators to know, innov... |
| 20.01.2022 | Shell forms $5M carbon capture research partnership with Houston-area university | Houston-based Shell Global Solutions and Prairie View A&M University signed a $5 million partnership this week that aims to foster innovative and effective carbon dioxide utilization and carbon capture methods.
The five-year research ag... |
| 13.01.2022 | Houston expert shares 3 venture capital predictions for 2022 | New Year’s resolutions are all well and good, but this year, in true VC fashion, I’m making some New Year’s predictions, too. Though I’m not an oracle, I am an investor, which means I use what I learned in the past to guide my decisions in ... |
| 04.01.2022 | These are the 2 Houston startups that joined the unicorn club in 2021 | Houston welcomed a duo of unicorns in 2021, according to a new report. But these unicorns aren’t those mythical multicolored creatures. Rather, they’re startups valued at $1 billion or more.
As of December 2021, there were more than 900 uni... |
| 04.06.2021 | New Research from Caris Life Sciences Finds Immunotherapy Resistance in Leiomyosarcoma | |
| 12.05.2021 | Caris Life Sciences scores $830M to grow AI-powered genetic sequencing platform
Remarque Systems: Content Hub | For most medtech startups, the dream of raising a billion dollars is nothing but a castle in the air. Caris Life Sciences, meanwhile, just made itself at home in that castle after surpassing the 10-figure mark over the course of two funding... |
| 12.05.2021 | Caris Life Sciences scores $830M to grow AI-powered genetic sequencing platform | For most medtech startups, the dream of raising a billion dollars is nothing but a castle in the air. Caris Life Sciences, meanwhile, just made itself at home in that castle after surpassing the 10-figure mark over the course of two funding... |
| 11.05.2021 | Caris Life Sciences Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform | |
| 11.05.2021 | Caris Life Sciences Raises $830M in Growth Equity Funding | Caris Life Sciences, an Irving, Texas-based innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, raised $830m in growth equity funding at a post-money valuation of $7.83 bi... |
| 11.05.2021 | Caris Life Sciences Raises $830 Million in Growth Equity Capital | - |
| 11.05.2021 | Caris Life Sciences : Raises $830 Million in Growth Equity Capital to Continue to Expand its Precision Medicine Platform | IRVING, Texas, May 11, 2021 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, announced an $830 million growth equity rou... |
| 11.05.2021 | Caris Life Sciences Gets $830 Million Investment From Sixth Street-Led Group | Caris Life Sciences has received an $830 million infusion from a group led by Sixth Street Partners, the companies said, the latest sign of private equity’s enthusiasm for investing at the intersection of healthcare and technology.
Other si... |
| 28.04.2021 | Caris Life Sciences Announces Appointment of Joseph E. Gilliam to Board of Directors | |
| 06.04.2021 | Pascale Foundation, Member of Italy's Institute of Hospitalization and Treatment, Joins Caris Life Sciences' Precision Oncology Alliance | |
| 24.03.2021 | Caris Life Sciences Launches HLA Genotype Reporting, the Newest Addition to its Suite of Comprehensive Molecular Science Offerings | |
| 09.03.2021 | Caris' Precision Oncology Alliance Continues to Grow Internationally as it Welcomes Curie Oncology from Singapore | |
| 02.03.2021 | Moores Cancer Center at UC San Diego Health Joins Caris' Precision Oncology Alliance | |
| 19.01.2021 | Caris Life Sciences Accurately Identifies 21 Cancer Types Using Artificial Intelligence Derived Molecular Signatures | |
| 01.12.2020 | Caris Life Sciences Announces Vall d´Hebron Institute of Oncology Joins its Precision Oncology Alliance | |
| 10.11.2020 | Caris Life Sciences Announces Huntsman Cancer Institute Joins its Precision Oncology Alliance | |
| 27.10.2020 | Caris Life Sciences : Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors | IRVING, Texas, Oct. 27, 2020 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that it has raised $310 million in growth capital.
The fina... |
| 27.10.2020 | Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors | |
| 27.10.2020 | Caris Life Sciences Raises $310M in Growth Funding | Caris Life Sciences, an Irving, Texas-based innovator in molecular science focused on precision medicine, raised $310m in growth funding.
The financing includes $235 million in equity financing co-led by Highland Capital Management and Coat... |
| 20.10.2020 | Winship Cancer Institute of Emory University Joins Caris' Precision Oncology Alliance | |
| 13.10.2020 | Caris Life Sciences Launches CODEai - Real-World Clinico-Genomic Data Platform Powered by Artificial Intelligence | |
| 29.09.2020 | New England Cancer Specialists Joins Caris Precision Oncology Alliance | |
| 22.09.2020 | Caris Precision Oncology Alliance Welcomes UT Southwestern Medical Center | |
| 25.08.2020 | Penn State Cancer Institute Joins Caris Life Sciences' Precision Oncology Alliance | |
| 14.10.2018 | Caris Life Sciences Raises $150M | Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation, today announced that it has raised $150 million in growth capital in the form of senior s... |
| 01.10.2018 | Caris Life Sciences Raises $150M in Growth Funding | Caris Life Sciences, an Irving, Texas-based provider of molecular science focused on fulfilling the promise of precision medicine through quality and innovation, raised $150m in funding.
The funding was provided in the form of senior secure... |
| 01.10.2018 | Caris Life Sciences Raises $150M |
IRVING, TX, Leading innovator in molecular science has raised $150M in growth capital from TPG Sixth Street Partners.
>> Click here for more funding data on Caris Life Sciences
>> To export Caris Life Sciences funding data t... |
| 12.01.2016 | Precision medicine software maker Syapse raises $25M | Patients, after all, are clamoring for precision medicine’s widespread adoption, Syapse President and Founder Jonathan Hirsch said in an interview at this week’s J.P. Morgan Healthcare Conference.
“They’re voting with their feet, choosing t... |
| 24.12.2007 | Caris & Co. Raises Intel Price Target to $29 On Strong PCs | Caris & Co. analyst Daniel Berenbaum today raised his price target on Intel (INTC) by a dollar to $29 after coming across some personal computer data points that suggest sales should be better than average in the first quarter. He also ... |
| - | Caris Life Sciences | “Caris fulfills the promise of precision oncology through advanced laboratory testing, including tumor profiling and blood-based cancer diagnostics.” |
| - | Precision medicine software maker Syapse raises $25M | Folding precision medicine into the broader healthcare system is a complex logistical challenge – there are countless moving pieces involved, such as integrating EHR records with complex genomic data and treatment information.
Palo Alto pre... |
| - | The 9 healthcare startups that took in the most cash as VCs made record bets on transforming pharmacies and biotech | Noom cofounder and CEO Saeju Jeong. Noom This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Global healthcare startups raised a record $34.7 billion in 2021's second quarter.
Caris Life Scie... |
